18F-FECh-PET in patients with brain tumors

Conditions: brain tumors
MedDRA version: 14.1Level: LLTClassification code 10061030Term: Brain tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

Registration Number: EUCTR2011-003227-35-IT

Lead Sponsor: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

patients with brain tumours at first diagnosis or with suspicion of recurrence after treatment
age 18-75 years
Patients who provide the written informed consent
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 50
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 10

Exclusion Criteria

pregnancy/feeding

Study & Design

Study Type: Interventional clinical trial of medicinal product

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: to dinstinguish the tumors border from normal brain and to identify the tumour's infiltration for choosing the most appropriate treatment<br>to differentiate between the recurrence from fibrosis/necrosis;Secondary Objective: nd;Primary end point(s): to dinstinguish the tumors border from normal brain and to identify the tumour's infiltration for choosing the most appropriate treatment<br>to differentiate between the recurrence from fibrosis/necrosis;Timepoint(s) of evaluation of this end point: 1 day

Secondary Outcome Measures